SCHEMBL29084066

SCHEMBL29084066

COc1cc(Nc2ncc(Br)c(Nc3ccccc3C(C)(C)O)n2)c(C)cc1N1CCC(N2CCN(C)CC2)CC1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 8/20 0.55
▸ ALK Q9UM73 12/20 0.54
▸ INSR P06213 11/20 0.54
▸ IGF1R P08069 11/20 0.54
▸ MAP4K1 Q92918 1/20 0.50
▸ CHEK1 O14757 1/20 0.49
▸ AURKA O14965 1/20 0.49
▸ NUAK1 O60285 1/20 0.49
▸ JAK2 O60674 1/20 0.49
▸ STK10 O94804 1/20 0.49
▸ PRKD3 O94806 1/20 0.49
▸ SLC34A2 O95436 1/20 0.49
▸ CHEK2 O96017 1/20 0.49
▸ ABL1 P00519 1/20 0.49
▸ CD74 P04233 1/20 0.49
▸ ERBB2 P04626 1/20 0.49
▸ LCK P06239 1/20 0.49
▸ FYN P06241 1/20 0.49
▸ FES P07332 1/20 0.49
▸ CSF1R P07333 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29084155 0.92 EGFR (0.56) EGFRALKINSRIGF1RPLK1
SCHEMBL29084120 0.92 EGFR (0.64) EGFRALKINSRIGF1RMAP4K1
SCHEMBL29084090 0.92 EGFR (0.55) EGFRALKINSRIGF1RFGFR3
SCHEMBL29084000 0.91 EGFR (0.56) EGFRALKINSRIGF1RCHEK1
SCHEMBL29084051 0.91 EGFR (0.56) EGFRALKINSRIGF1RPLK1
SCHEMBL29084091 0.91 EGFR (0.53) EGFRALKINSRIGF1RPLK1
SCHEMBL29083992 0.90 EGFR (0.54) EGFRALKINSRIGF1RPLK1
SCHEMBL29083978 0.90 EGFR (0.52) EGFRALKINSRIGF1RPLK1
SCHEMBL29083954 0.90 EGFR (0.51) EGFRALKINSRIGF1RMAP4K1
SCHEMBL29083948 0.89 MAP4K1 (0.48) EGFRALKIGF1RMAP4K1CHEK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116670127-A EGFR inhibitors and compositions and uses thereof 贝达药业股份有限公司 2023-08-29 — — CN claimed
WO-2022206797-A1 EGFR INHIBITOR, AND COMPOSITION AND USE THEREOF 贝达药业股份有限公司 2022-10-06 — — WO claimed
CN-116670127-A EGFR inhibitors and compositions and uses thereof 贝达药业股份有限公司 2023-08-29 — — CN disclosed
WO-2022206797-A1 EGFR INHIBITOR, AND COMPOSITION AND USE THEREOF 贝达药业股份有限公司 2022-10-06 — — WO disclosed
Send feedback